@article{e10399b6e38b45f09db3d6c5422c82e1,
title = "European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia",
keywords = "CHRONIC MYELOGENOUS LEUKEMIA, TYROSINE-KINASE INHIBITOR, DIAGNOSED CHRONIC-PHASE, CHROMOSOME-POSITIVE LEUKEMIAS, IMATINIB MESYLATE THERAPY, PATIENTS RECEIVING IMATINIB, ACUTE-RENAL-FAILURE, DASATINIB 100 MG, PULMONARY ARTERIAL-HYPERTENSION, ACUTE LYMPHOBLASTIC-LEUKEMIA, 3122 Cancers",
author = "Steegmann, {J. L.} and M. Baccarani and M. Breccia and Casado, {L. F.} and V. Garcia-Gutierrez and A. Hochhaus and D-W Kim and Kim, {T. D.} and Khoury, {H. J.} and {Le Coutre}, P. and J. Mayer and D. Milojkovic and Kimmo Porkka and D. Rea and G. Rosti and S. Saussele and R. Hehlmann and Clark, {R. E.}",
year = "2016",
month = aug,
doi = "10.1038/leu.2016.104",
language = "English",
volume = "30",
pages = "1648--1671",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer",
number = "8",
}